Prelude Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,833
| Closed | -$83K | – | 1818 |
|
|
2020
Q3 | $83K | Sell |
8,833
-1,294
| -13% | -$12.2K | ﹤0.01% | 741 |
|
|
2020
Q2 | $77K | Hold |
10,127
| – | – | ﹤0.01% | 714 |
|
|
2020
Q1 | $63K | Buy |
+10,127
| New | +$63K | ﹤0.01% | 441 |
|
|
2019
Q3 | – | Sell |
-897
| Closed | -$9K | – | 1767 |
|
|
2019
Q2 | $9K | Buy |
+897
| New | +$9K | ﹤0.01% | 1045 |
|
|
2019
Q1 | – | Sell |
-3,100
| Closed | -$47K | – | 1902 |
|
|
2018
Q4 | $47K | Buy |
+3,100
| New | +$47K | ﹤0.01% | 833 |
|
|
2018
Q1 | – | Sell |
-559
| Closed | -$7K | – | 1658 |
|
|
2017
Q4 | $7K | Sell |
559
-1,900
| -77% | -$23.8K | ﹤0.01% | 1107 |
|
|
2017
Q3 | $45K | Buy |
2,459
+2,059
| +515% | +$37.7K | ﹤0.01% | 1029 |
|
|
2017
Q2 | $7K | Sell |
400
-3,264
| -89% | -$57.1K | ﹤0.01% | 1324 |
|
|
2017
Q1 | $83K | Sell |
3,664
-25,443
| -87% | -$576K | 0.01% | 796 |
|
|
2016
Q4 | $1.01M | Buy |
29,107
+8,007
| +38% | +$279K | 0.12% | 193 |
|
|
2016
Q3 | $517K | Buy |
21,100
+9,691
| +85% | +$237K | 0.05% | 272 |
|
|
2016
Q2 | $273K | Buy |
11,409
+10,729
| +1,578% | +$257K | 0.04% | 375 |
|
|
2016
Q1 | $16K | Buy |
+680
| New | +$16K | ﹤0.01% | 1060 |
|
|
2015
Q4 | – | Sell |
-1,400
| Closed | -$56K | – | 1696 |
|
|
2015
Q3 | $56K | Buy |
1,400
+1,100
| +367% | +$44K | 0.01% | 953 |
|
|
2015
Q2 | $21K | Buy |
+300
| New | +$21K | ﹤0.01% | 1266 |
|
|
2014
Q4 | – | Sell |
-6,200
| Closed | -$198K | – | 2125 |
|
|
2014
Q3 | $198K | Sell |
6,200
-1,000
| -14% | -$31.9K | 0.03% | 656 |
|
|
2014
Q2 | $149K | Buy |
7,200
+3,900
| +118% | +$80.7K | 0.02% | 765 |
|
|
2014
Q1 | $64K | Buy |
+3,300
| New | +$64K | 0.01% | 1054 |
|
|
2013
Q4 | – | Sell |
-3,408
| Closed | -$73K | – | 1891 |
|
|
2013
Q3 | $73K | Buy |
+3,408
| New | +$73K | 0.01% | 774 |
|